Ann Arbor, MI, United States of America

Hacer Karatas

USPTO Granted Patents = 4 

Average Co-Inventor Count = 8.1

ph-index = 2

Forward Citations = 17(Granted Patents)


Company Filing History:


Years Active: 2015-2019

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Hacer Karatas: Innovator in BET Bromodomain Inhibitors

Introduction

Hacer Karatas is a prominent inventor based in Ann Arbor, MI (US). She has made significant contributions to the field of therapeutic methods, particularly through her work on BET bromodomain inhibitors. With a total of four patents to her name, her innovations are paving the way for advancements in cancer treatment.

Latest Patents

Hacer Karatas's latest patents focus on BET bromodomain inhibitors and therapeutic methods utilizing these compounds. The patents disclose inhibitors of BET bromodomains and compositions containing these inhibitors. Furthermore, they outline methods for using BET bromodomain inhibitors in treating diseases and conditions where inhibition of BET bromodomain provides therapeutic benefits, particularly in cancers.

Career Highlights

Hacer Karatas is affiliated with the University of Michigan, where she continues her research and development in the field of medicinal chemistry. Her work has garnered attention for its potential impact on cancer therapies, showcasing her dedication to improving patient outcomes through innovative solutions.

Collaborations

Hacer collaborates with esteemed colleagues such as Shaomeng Wang and Xu Ran, contributing to a dynamic research environment that fosters innovation and discovery.

Conclusion

Hacer Karatas stands out as a key inventor in the realm of BET bromodomain inhibitors, with her work promising to enhance therapeutic strategies for cancer treatment. Her contributions reflect a commitment to advancing medical science and improving health outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…